XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues:      
Total net sales $ 2,956,416 $ 2,971,956 $ 2,785,874
Costs and operating expenses:      
Costs and operating expenses 1,195,223 1,248,182  
Selling and administrative expenses 736,014 658,026 626,968
Research and development expenses 174,945 176,190 168,358
Purchased intangibles amortization 32,558 6,366 7,143
Litigation provision 0 0 5,165
Acquired in-process research and development 0 9,797  
Total costs and operating expenses 2,138,740 2,098,561 1,964,167
Operating income 817,676 873,395 821,707
Other income, net 807 2,228 17,203
Interest expense (98,861) (48,797) (44,938)
Interest income 16,621 11,020 12,221
Income before income taxes 736,243 837,846 806,193
Provision for income taxes 94,009 130,091 113,350
Net income $ 642,234 $ 707,755 $ 692,843
Net income per basic common share $ 10.87 $ 11.8 $ 11.25
Weighted-average number of basic common shares 59,076 59,985 61,575
Net income per diluted common share $ 10.84 $ 11.73 $ 11.17
Weighted-average number of diluted common shares and equivalents 59,270 60,331 62,028
Product [Member]      
Revenues:      
Total net sales $ 1,903,050 $ 1,988,169 $ 1,822,070
Costs and operating expenses:      
Costs and operating expenses 766,374 836,209 752,514
Service [Member]      
Revenues:      
Total net sales 1,053,366 983,787 963,804
Costs and operating expenses:      
Costs and operating expenses $ 428,849 $ 411,973 $ 404,019